Vit C 1000 liposomal

Nutritional information

* Recommended daily allowances (Directive 2008/100/EC amending -> Order 08.01.1992)

Discover our PureWay-C™ liposomal Vitamin C 1000

Vit C 1000 LEPIVITS combines 1000 mg of vitamin C with PureWay-C™ liposomal technology, featuring phospholipids from sunflower lecithin and citrus bioflavonoids. This patented form is designed to protect ascorbic acid and support its transport within the body.

Vitamin C contributes to the normal function of the immune system, to the reduction of tiredness and fatigue, to the protection of cells from oxidative stress, and to normal collagen formation for the normal function of the skin, cartilage, bones, blood vessels, teeth and gums.

As the human body does not naturally produce vitamin C, regular intake through the diet may be complemented, when necessary, by a high-strength formula. With 2 capsules per day, Vit C 1000 provides 1000 mg of ascorbic acid, in a plant-based pullulan capsule, with no added preservatives and no synthetic nanoparticles.

PureWay-C™ liposomal technology: vitamin C, phospholipids and bioflavonoids

PureWay-C™ technology combines vitamin C with natural phospholipids from sunflower lecithin. This liposomal approach is designed to support the transport of ascorbic acid, while providing a form of vitamin C studied for its cellular retention.

The available data on PureWay-C™ highlight higher cellular retention than certain conventional forms of vitamin C, such as ascorbic acid or calcium ascorbate, under the conditions of the cited study. To remain clear and transparent, this data should be presented as a technical feature linked to the patented ingredient, and not as a promise of individual effectiveness.

The formula is complemented by citrus bioflavonoids, naturally associated with citrus fruits, as well as a plant-based pullulan capsule. It contains no added preservatives, no synthetic nanoparticles, and is suitable for vegan routines.

Graph source: adapted from Weeks BS, Perez PP. Absorption rates and free radical scavenging values of vitamin C-lipid metabolites in human lymphoblastic cells. Medical Science Monitor. 2007;13(10).

Comparative in vitro study conducted on human H9 lymphoblastic cells. The results relate to the cellular retention of different forms of vitamin C under the experimental conditions of the study; they should not be interpreted as a promise of individual effect.